Case Of Drug-induced Pneumonitis Research Articles

A Case of Drug-induced Pneumonitis Caused by Over-the-counter Medicine, Bofu-tsusho-san

A Case of Drug-induced Pneumonitis Caused by Over-the-counter Medicine, Bofu-tsusho-san

肝細胞癌に対するミリプラチン動注療法後に発症した薬剤性肺障害の1例

肝細胞癌に対するミリプラチン動注療法後に発症した薬剤性肺障害の1例

Rituximab-Induced Pneumonitis on F-18 FDG PET/CT in Patient With Non-Hodgkin Lymphoma

Abstract:Pulmonary drug toxicity is increasingly being diagnosed as a cause of acute and chronic lung disease. We report a case of drug-induced pneumonitis after R-CHOP therapy for non-Hodgkin lymphoma in which a follow-up examination F-18 FDG PET/CT showed some patchy consolidations and ground-glas

A clinical study of twelve cases of drug-induced pneumonitis

Twelve cases of drug-induced pneumonitis were clinically investigated. Treatment of antimicrobial agents in 8 cases of drug-induced pneumonitis ranged from 7-21 days (mean 12 days) and that of other drugs in 4 cases from 18-150 days (mean 70 days). The patients developed fever and dyspnea at a high rate of frequency. Abnormal laboratory findings included increased IgE (44%), eosinophilia (36%), and increased GOT and GPT in 33%. Chest X-ray films revealed a large reticulo-nodular or ground glass shadows in both lung fields. The results of lymphocyte stimulation tests were positive in 5 of 11 cases (45%). Eight cases demonstrated a rapid improvement by discontinuation of the drug and corticosteroid was administered in 4 cases. The drug received by the patient and their known risk of pulmonary toxicity should be kept in mind in order to reach a diagnosis of drug-induced pneumonitis and grasp the clinical picture of this disease. A provocation test is potentially dangerous, therefore it should not be carried out lightly.

FDG positron emission tomography imaging of drug-induced pneumonitis

Several studies have reported the findings of fluorine-18-labeled fluoro-2-deoxy-D: -glucose positron emission tomography (FDG-PET) in benign lung disease with diffuse pulmonary injury; however, the characteristics and effectiveness of FDG-PET imaging for interstitial pneumonitis have not been substantiated. We report two cases of drug-induced pneumonitis in two patients treated for breast cancer who were diagnosed by FDG-PET examination. Both the cases showed diffuse interstitial infiltration in the bilateral lungs on computed tomography, but the degree of FDG accumulation was different. It is probable that the degree of FDG accumulation reflected the activity of the drug-induced pneumonitis. The present cases show very interesting FDG-PET imaging findings of diffuse lung disease.

Two Cases of Drug-induced Pneumonitis During Combined Treatment With Gold and Bucillamine

Two Cases of Drug-induced Pneumonitis During Combined Treatment With Gold and Bucillamine

A case of drug-induced pneumonitis after the treatment for <i>Helicobacter pylori</i>

A case of drug-induced pneumonitis after the treatment for <i>Helicobacter pylori</i>